Analyst Ratings for Maze Therapeutics (MAZE)
MAZE Rating Summary
MAZE Price Target Summary
- Highest: $110.00 (H.C. Wainwright)
- Lowest: $46.00 (Guggenheim)
- Average: $63.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$63.75 (+105.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/19/2026 | Canaccord | Whitney Ijem | New Coverage | Buy (N/A) |
75.00 (N/A) |
27.53 (31.07) |
12.86% | Details |
| 9/23/2026 | CIBC | Eric Joseph | New Coverage | Outperformer (N/A) |
50.00 (N/A) |
28.38 (31.07) |
9.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
